美国 · 平台与数据 · MarketBeat
Climb Bio (NASDAQ:CLYM) Stock Gets Downgrade from Wall Street Zen

详细摘要
Wall Street Zen cut Climb Bio from a "hold" rating to a "sell" rating in a report on Sunday.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)



